Pricing Log in Create free account
Wednesday 14 October 2026 Export HUM’s income statement to Excel — free account

Humana Inc.

HUM Healthcare Healthcare Plans

Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024. In the quarter to June 2026, revenue grew 26.2%, EPS grew 27.9%, free cash flow grew 58.5% and total debt rose 13.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.

420.38 13.12 −3.03%
Market cap
$52.1B
P/E
39.5×
Fwd P/E
42.9×
Dividend yield
0.84%
F-score
6/9
Altman Z
4.66
Beneish M
−2.29
Dividend safety
61/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Humana Inc. (HUM) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Oct 13, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Oct 9, 2026 7.01 Regulation FD disclosure
8-K Sep 1, 2026 7.01 Regulation FD disclosure
10-Q Jun 30, 2026 P1I2: 4 added · 2 removed · 44 modified
P2I1A: no changes
8-K Jul 28, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits Officer departure
8-K Jul 29, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jun 1, 2026 7.01 Regulation FD disclosure
8-K May 15, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K Apr 29, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Apr 16, 2026 5.07 Submission of matters to a vote of security holders
8-K Apr 10, 2026 5.02 Departure or appointment of directors or officers
8-K Mar 5, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Mar 2, 2026 7.01 Regulation FD disclosure
10-K Dec 31, 2025 1: 1 added · 4 removed · 30 modified
1A: 2 added · 2 removed · 39 modified
7: 18 added · 20 removed · 64 modified
8-K Feb 11, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Dec 16, 2025 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Dec 1, 2025 7.01 Regulation FD disclosure
10-Q Sep 30, 2025
8-K Nov 5, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Oct 2, 2025 7.01 Regulation FD disclosure
8-K Aug 29, 2025 7.01 Regulation FD disclosure
10-Q Jun 30, 2025
10-K Dec 31, 2024

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.